AAPL   322.32 (-0.86%)
MSFT   182.92 (-1.32%)
FB   226.29 (-1.68%)
GOOGL   1,414.30 (-1.73%)
AMZN   2,460.60 (-0.72%)
NVDA   350.66 (-0.03%)
CGC   16.63 (+0.36%)
BABA   218.04 (-0.26%)
MU   51.22 (+4.70%)
GE   7.74 (+5.16%)
TSLA   864.38 (-2.10%)
AMD   52.63 (-0.19%)
T   31.80 (+0.92%)
ACB   14.23 (-0.49%)
F   6.57 (+6.14%)
GILD   77.54 (+4.22%)
DIS   123.69 (+1.24%)
NFLX   414.33 (-1.81%)
BAC   26.78 (+3.04%)
BA   184.30 (+6.43%)
AAPL   322.32 (-0.86%)
MSFT   182.92 (-1.32%)
FB   226.29 (-1.68%)
GOOGL   1,414.30 (-1.73%)
AMZN   2,460.60 (-0.72%)
NVDA   350.66 (-0.03%)
CGC   16.63 (+0.36%)
BABA   218.04 (-0.26%)
MU   51.22 (+4.70%)
GE   7.74 (+5.16%)
TSLA   864.38 (-2.10%)
AMD   52.63 (-0.19%)
T   31.80 (+0.92%)
ACB   14.23 (-0.49%)
F   6.57 (+6.14%)
GILD   77.54 (+4.22%)
DIS   123.69 (+1.24%)
NFLX   414.33 (-1.81%)
BAC   26.78 (+3.04%)
BA   184.30 (+6.43%)
AAPL   322.32 (-0.86%)
MSFT   182.92 (-1.32%)
FB   226.29 (-1.68%)
GOOGL   1,414.30 (-1.73%)
AMZN   2,460.60 (-0.72%)
NVDA   350.66 (-0.03%)
CGC   16.63 (+0.36%)
BABA   218.04 (-0.26%)
MU   51.22 (+4.70%)
GE   7.74 (+5.16%)
TSLA   864.38 (-2.10%)
AMD   52.63 (-0.19%)
T   31.80 (+0.92%)
ACB   14.23 (-0.49%)
F   6.57 (+6.14%)
GILD   77.54 (+4.22%)
DIS   123.69 (+1.24%)
NFLX   414.33 (-1.81%)
BAC   26.78 (+3.04%)
BA   184.30 (+6.43%)
AAPL   322.32 (-0.86%)
MSFT   182.92 (-1.32%)
FB   226.29 (-1.68%)
GOOGL   1,414.30 (-1.73%)
AMZN   2,460.60 (-0.72%)
NVDA   350.66 (-0.03%)
CGC   16.63 (+0.36%)
BABA   218.04 (-0.26%)
MU   51.22 (+4.70%)
GE   7.74 (+5.16%)
TSLA   864.38 (-2.10%)
AMD   52.63 (-0.19%)
T   31.80 (+0.92%)
ACB   14.23 (-0.49%)
F   6.57 (+6.14%)
GILD   77.54 (+4.22%)
DIS   123.69 (+1.24%)
NFLX   414.33 (-1.81%)
BAC   26.78 (+3.04%)
BA   184.30 (+6.43%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ADMA BiologicsAutolus TherapeuticsGritstone OncologySutro BiopharmaHarpoon Therapeutics
SymbolNASDAQ:ADMANASDAQ:AUTLNASDAQ:GRTSNASDAQ:STRONASDAQ:HARP
Price Information
Current Price$3.10$13.05$6.53$10.18$17.31
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score2.21.41.82.11.3
Analysis Score3.43.53.53.43.5
Community Score3.02.42.72.42.2
Dividend Score0.00.00.00.00.0
Ownership Score4.01.02.04.01.0
Earnings & Valuation Score0.60.00.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$7.40$22.67$17.00$18.67$31.17
% Upside from Price Target138.71% upside73.69% upside160.34% upside83.37% upside80.05% upside
Trade Information
Market Cap$250.40 million$513.47 million$234.02 million$234.84 million$435 million
Beta2.052.091.410.431.33
Average Volume2,602,317169,710165,21371,187142,184
Sales & Book Value
Annual Revenue$29.35 million$2.91 million$4.36 million$42.74 million$5.78 million
Price / Sales9.12180.0455.815.5374.86
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.44 per share$6.35 per share$3.75 per share$4.24 per share$3.82 per share
Price / Book7.052.061.742.404.53
Profitability
Net Income$-48,280,000.00$-123,850,000.00$-94,430,000.00$-55,740,000.00$-55,570,000.00
EPS($0.92)($2.88)($2.81)($2.43)($2.55)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-151.18%-9,870.67%-2,397.90%-148.06%-681.41%
Return on Equity (ROE)-105.97%-45.59%-69.76%-59.70%-53.62%
Return on Assets (ROA)-35.21%-38.88%-52.35%-36.43%-34.20%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.02%0.08%0.17%0.29%0.16%
Current Ratio11.90%10.78%6.09%3.98%5.40%
Quick Ratio8.14%10.78%6.09%3.98%5.40%
Ownership Information
Institutional Ownership Percentage56.12%38.12%77.61%51.10%77.13%
Insider Ownership Percentage15.20%N/A38.00%28.90%34.90%
Miscellaneous
Employees314N/A11314145
Shares Outstanding86.35 million40.15 million37.27 million23.23 million25.00 million
Next Earnings Date8/13/2020 (Estimated)N/A8/10/2020 (Estimated)8/12/2020 (Estimated)8/3/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.